Showing 501 - 520 results of 123,408 for search '(( 2 d decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.73s Refine Results
  1. 501
  2. 502

    SPL treatment decreases diabetes-induced co-immunoprecipitation (co-IP) of cldn-4 and -8. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…Also, increased co-IP of cldn-8 with cldn-4 was found under diabetic condition and SPL decreased this interaction (C), densitometric analysis show that these changes were significant (D) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s005" target="_blank">S5 Fig</a>). …”
  3. 503

    Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

    Published 2011
    “…We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”
  4. 504
  5. 505
  6. 506

    Effect of OKN-007 on the immunoexpression of SULF2 in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

    Published 2015
    “…(D) OKN-007 significantly decreased the immunoexpression of SULF2 (%) in the treated responsive group (n = 4) when compared to the untreated animals (n = 3). …”
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514
  15. 515
  16. 516
  17. 517
  18. 518
  19. 519
  20. 520

    Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

    Published 2023
    “…(<b>H</b>) Quantification (1.00 ± 0.09 for control, 0.45 ± 0.03 for cKO); unpaired two-tailed Student’s <i>t</i> test (mean ± SEM; <i>p</i> < 0.0001 [****] at P4/P5; <i>p</i> = 0.0004 [***] at P8/P9; <i>p</i> = 0.0012 [**] at P12/P13). …”